Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 2015 Feb 9;212(2):281. doi: 10.1084/jem.2013097701202015c

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups

Marie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, Jeremy Price, Hitoshi Takizawa, Hélène Salmon, Juliana Idoyaga, Albert Ruzo, Philip J Lupo, M John Hicks, Albert Shih, Stephen J Simko, Harshal Abhyankar, Rikhia Chakraborty, Marylene Leboeuf, Monique Beltrão, Sérgio A Lira, Kenneth M Heym, Björn E Clausen, Venetia Bigley, Matthew Collin, Markus G Manz, Kenneth McClain, Miriam Merad, Carl E Allen
PMCID: PMC4322054  PMID: 25646268

Vol. 211, No. 4, April 7, 2014. Pages 669–683.

The authors regret that Björn E. Clausen did not appear in the original author list. His affiliation is Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany. The HTML and PDF versions of this article have been corrected.


Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES